Schmidt, H. A., Rodolph, M., Schaefer, R., Baggaley, R., & Doherty, M. (2022). Long‐acting injectable cabotegravir: Implementation science needed to advance this additional HIV prevention choice. Journal of the International AIDS Society, 25(7), 1. https://doi.org/10.1002/jia2.25963
Chicago Style (17th ed.) CitationSchmidt, Heather‐Marie Ann, Michelle Rodolph, Robin Schaefer, Rachel Baggaley, and Meg Doherty. "Long‐acting Injectable Cabotegravir: Implementation Science Needed to Advance This Additional HIV Prevention Choice." Journal of the International AIDS Society 25, no. 7 (2022): 1. https://doi.org/10.1002/jia2.25963.
MLA (9th ed.) CitationSchmidt, Heather‐Marie Ann, et al. "Long‐acting Injectable Cabotegravir: Implementation Science Needed to Advance This Additional HIV Prevention Choice." Journal of the International AIDS Society, vol. 25, no. 7, 2022, p. 1, https://doi.org/10.1002/jia2.25963.